Differential Expression of Plasma Cytokines in Sepsis Patients and Their Clinical Implications

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2024 Sep 9

PMID 39247745

Authors

Hui-Xiu Liu

Yu-Ying Wang

Xue-Feng Yang

Affiliations

Soon will be listed here.

Abstract

Background: Sepsis, which is characterized by acute systemic inflammation and is associated with high rates of morbidity and mortality, presents a significant challenge in health care. Some scholars have found that the sequential organ failure assessment (SOFA) and quick SOFA scores are not ideal for predicting severe sepsis and mortality. Microbial culture takes a long time (2-3 d) and provides no information for early diagnosis and treatment. Therefore, new diagnostic methods for sepsis need to be explored.

Aim: To assess cytokine levels in the plasma of sepsis patients and identify potential biomarkers for diagnosing sepsis.

Methods: Ten sepsis patients admitted to the emergency department within 24 h of onset were enrolled as the observation group, whereas ten noninfected patients served as the control group. Of the 10 noninfected patients, 9 hypertension combined with cerebral infarction, 1 patients with vertiginous syndrome. Plasma Cytokines were measured using the Bio-Plex Pro™ Human Chemokine Panel 40-plex. Differentially expressed cytokines in plasma of sepsis and nonsepsis patients were analyzed using Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.

Results: Interleukin (IL)-16, granulocyte-macrophage granulocyte-macrophage colony-stimulating factor (GM-CSF), CX3CL1, CXCL9, CXCL16, CCL25, and CCL23 plasma levels were significantly increased in sepsis patients. GO analysis revealed that these cytokines were mainly associated with cellular structures such as intermediates, nuclear plaques, adhesion plaques, lateral plasma membranes, and cell matrix junctions. These genes were involved in various molecular functions, such as cytokine activity, receptor ligand activity, and signal receptor activator activity, contributing to various biological functions, such as leukocyte chemotaxis, migration, and chemotaxis. KEGG analysis indicated involvement in cytokine cytokine receptor interactions, chemokine signaling pathways, virus-protein interactions with cytokines and cytokine receptors, and the tumor necrosis factor signaling pathway.

Conclusion: Elevated serum levels of IL-16, GM-CSF, CX3CL1, CXCL9, CXCL16, CCL25, and CCL23 in sepsis patients suggest their potential as diagnostic biomarkers for sepsis.

References

Martinez-Garcia J, Martinez-Banaclocha H, Angosto-Bazarra D, Torre-Minguela C, Baroja-Mazo A, Alarcon-Vila C . P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis. Nat Commun. 2019; 10(1):2711. PMC: 6586640. DOI: 10.1038/s41467-019-10626-x. View

Wilbanks A, Zondlo S, Murphy K, Mak S, Soler D, Langdon P . Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol. 2001; 166(8):5145-54. DOI: 10.4049/jimmunol.166.8.5145. View

Prakash V, Arora V, Jindal A, Maiwall R, Sarin S . Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult-to-treat spontaneous bacterial peritonitis: A randomized controlled trial. Liver Int. 2023; 43(6):1298-1306. DOI: 10.1111/liv.15534. View

Ellett F, Jorgensen J, Marand A, Ming Liu Y, Martinez M, Sein V . Diagnosis of sepsis from a drop of blood by measurement of spontaneous neutrophil motility in a microfluidic assay. Nat Biomed Eng. 2018; 2(4):207-214. PMC: 6166236. DOI: 10.1038/s41551-018-0208-z. View

Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G . Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016; 68:98-104. PMC: 4803021. DOI: 10.1016/j.jaut.2016.01.001. View

Huang H, Wang S, Jiang T, Fan R, Zhang Z, Mu J . High levels of circulating GM-CSFCD4 T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study. Cell Mol Immunol. 2018; 16(6):602-610. PMC: 6804788. DOI: 10.1038/s41423-018-0164-2. View

Xia D, Wang S, Liu A, Li L, Zhou P, Xu S . CCL25 Inhibition Alleviates Sepsis-Induced Acute Lung Injury and Inflammation. Infect Drug Resist. 2022; 15:3309-3321. PMC: 9241997. DOI: 10.2147/IDR.S352544. View

Moreno R, Rhodes A, Piquilloud L, Hernandez G, Takala J, Gershengorn H . The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update?. Crit Care. 2023; 27(1):15. PMC: 9837980. DOI: 10.1186/s13054-022-04290-9. View

Oakley R, Ramamoorthy S, Foley J, Busada J, Lu N, Cidlowski J . Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice. FASEB J. 2018; 32(10):5258-5271. PMC: 6133704. DOI: 10.1096/fj.201701153R. View

10.

Korbecki J, Bajdak-Rusinek K, Kupnicka P, Kapczuk P, Siminska D, Chlubek D . The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases. Int J Mol Sci. 2021; 22(7). PMC: 8036711. DOI: 10.3390/ijms22073490. View

11.

Ginde A, Blatchford P, Trzeciak S, Hollander J, Birkhahn R, Otero R . Age-related differences in biomarkers of acute inflammation during hospitalization for sepsis. Shock. 2014; 42(2):99-107. PMC: 4101036. DOI: 10.1097/SHK.0000000000000182. View

12.

Zhang C, Li X, Liu N, Feng Z, Zhang C . MicroRNA-96 is Downregulated in Sepsis Neonates and Attenuates LPSInduced Inflammatory Response by Inhibiting IL-16 in Monocytes. Comb Chem High Throughput Screen. 2020; 25(1):90-96. DOI: 10.2174/1386207323666201211091312. View

13.

Ricano-Ponce I, Riza A, de Nooijer A, Pirvu A, Dorobantu S, Dragos A . Characterization of sepsis inflammatory endotypes using circulatory proteins in patients with severe infection: a prospective cohort study. BMC Infect Dis. 2022; 22(1):778. PMC: 9547371. DOI: 10.1186/s12879-022-07761-0. View

14.

Kakimi K, Lane T, Wieland S, Asensio V, Campbell I, Chisari F . Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med. 2001; 194(12):1755-66. PMC: 2193580. DOI: 10.1084/jem.194.12.1755. View

15.

Center D, Cruikshank W, Parada N, Ryan T, Theodore A, Viglianti G . Measurement of interleukin 16. Curr Protoc Immunol. 2008; Chapter 6:6.23.1-6.23.14. DOI: 10.1002/0471142735.im0623s22. View

16.

Smyth L, Starkey C, Gordon F, Vestbo J, Singh D . CD8 chemokine receptors in chronic obstructive pulmonary disease. Clin Exp Immunol. 2008; 154(1):56-63. PMC: 2561084. DOI: 10.1111/j.1365-2249.2008.03729.x. View

17.

Hofnagel O, Engel T, Severs N, Robenek H, Buers I . SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion. Atherosclerosis. 2011; 217(2):371-8. DOI: 10.1016/j.atherosclerosis.2011.04.021. View

18.

Shimaoka T, Nakayama T, Kume N, Takahashi S, Yamaguchi J, Minami M . Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J Immunol. 2003; 171(4):1647-51. DOI: 10.4049/jimmunol.171.4.1647. View

19.

Sun J, Zhang H, Liu D, Cui L, Wang Q, Gan L . A Functional Variant of CXCL16 Is Associated With Predisposition to Sepsis and MODS in Trauma Patients: Genetic Association Studies. Front Genet. 2021; 12:720313. PMC: 8446271. DOI: 10.3389/fgene.2021.720313. View

20.

Parada N, Center D, Kornfeld H, Rodriguez W, Cook J, Vallen M . Synergistic activation of CD4+ T cells by IL-16 and IL-2. J Immunol. 1998; 160(5):2115-20. View